Literature DB >> 35943579

Trans-anal surgery with the taTME technique for rectal gastrointestinal stromal tumors: a retrospective study.

Takahiro Shigaki1, Yuichiro Tsukada1, Koichi Teramura1, Hiro Hasegawa1, Koji Ikeda1, Yuji Nishizawa1, Takeshi Sasaki1, Masaaki Ito2.   

Abstract

PURPOSE: Rectal gastrointestinal stromal tumors (GISTs) surgery is often challenging owing to the anatomical constraints of the narrow pelvis and tumor hugeness. Despite the increasing number of patients undergoing trans-anal total mesorectal excision (taTME) globally, the feasibility of trans-anal surgery with the taTME technique for rectal GISTs remains unclear. We aimed to evaluate the feasibility of trans-anal surgery with the taTME technique for rectal GISTs.
METHODS: Using a prospectively collected database, we retrospectively analyzed the clinical findings, surgical outcomes, pathological outcomes, urinary and anal functions, and prognoses of patients who underwent trans-anal surgery with the taTME technique for primary rectal GISTs at the National Cancer Center Hospital East from September 2014 to March 2020.
RESULTS: Twenty-one patients with primary rectal GISTs were included in this study. The median distance from the anal verge to the lower edge of the tumor was 40 mm (range, 15-60 mm), and the median tumor size was 59 mm (range, 11-175 mm). Moreover, seven and 14 patients underwent one-team and two-team surgeries, respectively, with curative intent. Nineteen patients (90.5%) underwent anus-preserving surgery, and the urinary tracts were preserved in all cases. Two-team surgery showed a significantly lower blood loss volume and shorter operation time than one-team surgery (58 vs. 222 mL, P = 0.017; 184 vs 356 min, P = 0.041, respectively). The pathological negative-margin resection rate was 100%. During the follow-up period, no patient developed local GIST recurrence and one (4.8%) developed distant metastasis.
CONCLUSION: Trans-anal surgery with the taTME technique is feasible for rectal GISTs, and two-team surgery may be more advantageous than one-team surgery in terms of operation time and blood loss.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Gastrointestinal stromal tumor; Rectum; Trans-anal surgery; Two-team surgery; taTME

Mesh:

Year:  2022        PMID: 35943579     DOI: 10.1007/s00384-022-04233-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.796


  41 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.

Authors:  M J Wilkinson; J E F Fitzgerald; D C Strauss; A J Hayes; J M Thomas; C Messiou; C Fisher; C Benson; P P Tekkis; I Judson
Journal:  Br J Surg       Date:  2015-05-13       Impact factor: 6.939

3.  Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.

Authors:  Yoshiya Fujimoto; Takashi Akiyoshi; Tsuyoshi Konishi; Satoshi Nagayama; Yosuke Fukunaga; Masashi Ueno
Journal:  Int J Colorectal Dis       Date:  2013-09-10       Impact factor: 2.571

4.  The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000.

Authors:  Thomas Tran; Jessica A Davila; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

Review 5.  Gastrointestinal stromal tumors: biology and treatment.

Authors:  Florence Duffaud; Jean-Yves Blay
Journal:  Oncology       Date:  2003       Impact factor: 2.935

6.  Gastrointestinal stromal tumor of the rectum resected by laparoscopic surgery: report of a case.

Authors:  Takatoshi Nakamura; Atsushi Ihara; Hiroyuki Mitomi; Yukihito Kokuba; Takeo Sato; Heita Ozawa; Kazuhiko Hatade; Wataru Onozato; Masahiko Watanabe
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

7.  Rare case of gastrointestinal stromal tumor of the anal canal.

Authors:  Madhu Kumar; Madhu Mati Goel; Devendra Singh
Journal:  J Cancer Res Ther       Date:  2013 Oct-Dec       Impact factor: 1.805

8.  Anorectal gastrointestinal stromal tumor: a case report and literature review.

Authors:  Sanjeev Singhal; Anu Singhal; Rahul Tugnait; Vineet Varghese; Bishwanath Tiwari; Pankaj K Arora; Pawan Malik; Mriganka Deuri Bharali; Ankur Subhash Dhuria; Pushkar Chauhan; Chandrakant Singh; Amit Ballani; Vishnu Panwar
Journal:  Case Rep Gastrointest Med       Date:  2013-03-25

9.  Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.

Authors:  Kennoki Kyo; Masaki Azuma; Kazuya Okamoto; Motohiro Nishiyama; Takahiro Shimamura; Atsushi Maema; Hitoshi Kanamaru; Motoaki Shirakawa; Toshio Nakamura; Kazuya Shinmura; Kenji Koda; Hidetaro Yokoyama
Journal:  World J Surg Oncol       Date:  2016-03-08       Impact factor: 2.754

10.  Preoperative imatinib and laparoscopic intersphincteric resection for large rectal gastrointestinal stromal tumor: A case report.

Authors:  Shinnosuke Nagano; Norikatsu Miyoshi; Tsuyoshi Takahashi; Hiroaki Itakura; Shiki Fujino; Takayuki Ogino; Hidekazu Takahashi; Mamoru Uemura; Chu Matsuda; Tsunekazu Mizusima; Masaki Mori; Yuichiro Doki
Journal:  Int J Surg Case Rep       Date:  2020-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.